Menu IR Home IR Home News Releases Events and Presentations Stock Information Stock Quote Interactive Stock Chart Key Ratios Analyst Coverage FAQs Financials and SEC Filings Annual Reports and Proxies Quarterly Financial Reports SEC Filings Corporate Governance Documents and Charters Management Board of Directors Committee Composition Contact the Board Contact Us News Releases Investor Alerts Year All Years 2020 2019 2018 2017 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard May 30, 2019 Immunic, Inc. to Participate in Investor and Scientific Conferences in June May 9, 2019 Immunic, Inc. to Participate in Upcoming May Conferences Apr 29, 2019 Immunic, Inc. Appoints Industry Veteran Tamara A. Seymour as Interim Chief Financial Officer Apr 12, 2019 Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases - Developing Oral Therapies with Best-in-Class Potential - Apr 10, 2019 Vital Therapies, Inc. Announces Filing of its Form 10-Q for the Quarter Ended March 31, 2019 Show 5102550100 per page«1234567891011»
